10月13日，Alignment Healthcare盘中上涨8.61%，报8.195美元/股，成交额3579.04万美元。此前该股因加州HMO计划CMS星级评级下调预期及诉讼风险连续重挫，跌至两年多低点。
消息面上，瑞银将Alignment Healthcare目标价从22美元大幅下调至9美元，但仍维持中性评级，该目标价较当前股价仍有约10%的上行空间，成为短线反弹的催化因素。参考信息显示，公司在七份Medicare Advantage合同中仍有六份获得4星或以上评级，基本面并未全面恶化，市场正在重新评估过度抛售后的风险收益比。
Alignment Healthcare, Inc.于2013年在特拉华州成立，其使命是：一次性改善一名老年人的健康状况。Alignment是新一代以消费者为中心的平台，正在革新老年人的医疗保健体验。该公司通过其Medicare Advantage计划提供了这种体验，该计划是为满足美国各地老年人的需求而量身定制的。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.